Gain Important Insights into Clinical Trials at the 13th Annual Clinical Trials in CNS Event

SMi is delighted to announce its 13th annual Clinical Trials in CNS Conference that will be held in London. With an ever increasing average life expectancy, neurodegenerative diseases are becoming more prevalent in society.
 
 
Clinical Trials in CNS
Clinical Trials in CNS
 
Spread the Word
Listed Under

Tags:
Clinical Trials
Cns
Pharma
Central Nervous System
Trial Design

Industrys:
Event
Health

Location:
London City - London, Greater - England

Subject:
Events

LONDON - July 4, 2014 - PRLog -- SMi is delighted to announce its 13th annual Clinical Trials in CNS Conference. With an ever increasing average life expectancy, neurodegenerative diseases are becoming more prevalent in society. With this comes the need for new and improved therapies for treating neurodegenerative conditions. From Alzheimer's to Parkinson's disease, the target and mechanism by which a disease manifests itself presents unique challenges in how to approach such treatments not to mention ethical and legal issues behind treatment and trial design.

This conference will give delegates the opportunity to gain additional insights into the best practices in clinical trials, as well as address the challenges in CNS research and by looking at the latest pre-clinical and clinical studies.

This is an opportunity not to be missed, as we delve into the complex and exciting world of Central Nervous System discovery, allowing delegates to learn, explore and debate the key areas of CNS, its preclinical discovery and its clinical trials.

Reasons to Attend:

• Examine the multi-stakeholder approach to self-management and multidisciplinary care in patients with MS

• Discuss the past, present and future of CNS medicines research

• Analyse novel biomarkers for the brain

• Understand the recent failures in CNS development and how translation did not work

• Review the collaboration between industry and academic partnering


Key Speakers:

Tine Bryan Stensbøl, Divisional Director Discovery Pharmacology Research, Lundbeck

Alan Palmer, Co-Founder and Director, MS Therapeutics

Veronique Bragulat, Clinical Imaging Manager, GSK

Sophie Dix, Senior Research Scientist, Neurodegenerative Disease Drug Hunting Team, Eli Lilly

David Willé, Applied Statistician, GSK

Peter Joseph Jongen, Founding Director, MS4 Research Institute

Ernst-Wilhelm Radue, CEO, MIAC AG

Edwin Johnson, Director, Stockholm Brain Institute

Shahid Zaman, Affiliated Lecturer, University of Cambridge

For more information please visit www.smi-online.co.uk/2014clinicaltrialscns53.asp

If you would like to attend this conference as a delegate please contact Filipa Ribeiro on +44 (0) 207 827 6020 or e-mail fribeiro@smi-online.co.uk

If you are interested in sponsoring this event contact Alia Malick on +44(0)20 7827 6168 or email amalick@smi-online.co.uk

If you would like to become a media partner contact Sarah Watson on +44 (0)20 7827 6134 or email swatson@smi-online.co.uk

Contact
Sarah Watson
0207 827 6134
swatson@smi-online.co.uk
End
Source:
Email:***@smi-online.co.uk Email Verified
Tags:Clinical Trials, Cns, Pharma, Central Nervous System, Trial Design
Industry:Event, Health
Location:London City - London, Greater - England
Subject:Events
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
SMi Group Ltd. PRs
Trending News
Top Daily News
Top Weekly News



Like PRLog?
9K2K1K
Click to Share